iShares MSCI World ETF: A Fee Premium Tested by Record Profits

iShares MSCI World ETF surges on tech earnings but faces cost scrutiny from rivals and headwinds from new tariffs and index changes.

The iShares MSCI World ETF (URTH) is navigating a complex landscape, propelled to new heights by blockbuster earnings while facing intensifying pressure on its cost structure. The fund recently surged to a 52-week high of $193.60, marking a nearly 10% gain over just two weeks. This rally has been powered by a familiar engine: the colossal weight of US technology giants within its portfolio.

Nvidia leads the pack with a 5.29% weighting, followed by Apple at 4.55% and Microsoft at 3.16%. Together, these three stocks command over 13% of the ETF's $7.94 billion in assets under management. The technology sector overall dominates the portfolio with a weighting exceeding 26%. This concentration has driven the fund significantly above its 200-day moving average, with technical indicators like the RSI and MACD signaling sustained bullish momentum. For the uptrend to hold, analysts note the price must remain above key support levels at $187.34 and $184.64.

Yet, the first-quarter 2026 earnings season introduced a powerful counterweight to this tech-heavy narrative. The financial sector, the ETF's second-largest allocation, delivered staggering results. Morgan Stanley capped the season with profits soaring 29% to $5.57 billion on revenue of $20.58 billion, the first time the bank has crossed the $20 billion mark in a single quarter. Its equities trading revenue jumped 25% to a record $5.15 billion. This followed strong reports from JPMorgan Chase, which posted record trading revenue of $11.6 billion, and Goldman Sachs. FactSet data indicates the S&P 500 is on track for its sixth consecutive quarter of double-digit earnings growth, the longest such streak in over a decade.

Despite this performance, URTH's expense ratio of 0.24% is coming under scrutiny. A fee war is heating up among competitors. Invesco slashed the fee on its MSCI World ETF to 0.05% on April 1, following similar moves by UBS and BNP Paribas. This leaves URTH's total expense ratio 19 basis points above the cheapest rival. BlackRock, the fund's manager, counters by highlighting URTH's tight tracking difference of just 0.02%. Institutional loyalty appears intact for now, evidenced by the Royal Bank of Canada increasing its position by 17.5% to roughly two million shares in Q4 2025. Morningstar maintains a Bronze rating on the fund but notes it could be cheaper.

Looking ahead, two significant challenges loom. In early April, the US administration imposed staggered tariffs on imported pharmaceutical products, effective from the end of July 2026. These range from 100% for firms without US pricing agreements to 10% for UK imports. Analysts project these measures could add around 0.5 percentage points to inflation and squeeze corporate margins. Furthermore, an upcoming MSCI index review in May, implementing a new free-float classification system, is expected to trigger more substantial portfolio adjustments than the modest Q1 review, which saw 18 additions and 27 deletions.

The ETF, which exhibits moderate volatility with a beta of 0.94, continues to see robust daily trading volume averaging over 720,000 shares. It is scheduled to trade ex-dividend on June 15, 2026, following a year where dividend growth surpassed 20%. If the fund can maintain support at its recent high, the psychologically significant $200 level emerges as the next clear technical target.